By Michele Maatouk
Date: Thursday 10 Oct 2019
(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.
No recent information was found.
GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
Deal speeds drugs sector consolidation | 26-Sep-2006 | The Herald |
No recent information was found.
No recent information was found.
Currency | Euro |
Share Price | 201.00 |
Change Today | 3.70 |
% Change | 1.88 % |
52 Week High | 201.90 |
52 Week Low | 129.35 |
Volume | 137,106 |
Shares Issued | 190.00m |
Market Cap | 38,190m |
Beta | 1.64 |
Strong Buy | 7 |
Buy | 10 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 21 |
Time | Volume / Share Price |
17:35 | 114 @ 201.00 |
17:35 | 63 @ 201.00 |
17:35 | 71 @ 201.00 |
17:35 | 67 @ 201.00 |
17:35 | 52 @ 201.00 |
You are here: research